Skip to main content

Market Overview

Benchmark Initiates Applied DNA Sciences With Speculative Buy


Analysts at Benchmark initiated coverage on Applied DNA Sciences Inc (NASDAQ: APDN) with a Speculative Buy rating.

The target price for Applied DNA Sciences is set to $5.

Applied DNA Sciences shares have dropped 61.36 percent over the past 52 weeks, while the S&P 500 index has surged 11.87 percent in the same period.

Applied DNA Sciences' shares rose 2.41 percent to close at $2.55 on Friday.

Latest Ratings for APDN

Feb 2021Roth CapitalInitiates Coverage OnBuy
Jan 2021HC Wainwright & Co.MaintainsBuy
Jan 2021HC Wainwright & Co.MaintainsBuy

View More Analyst Ratings for APDN
View the Latest Analyst Ratings


Related Articles (APDN)

View Comments and Join the Discussion!

Posted-In: BenchmarkInitiation Analyst Ratings

Latest Ratings

CSXRaymond JamesMaintains105.0
UPSRaymond JamesMaintains200.0
XPORaymond JamesMaintains145.0
JBHTRaymond JamesMaintains180.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at